The Capitol LedgerEvery move in Congress, on the record
HomeBillsRecordsLedger AI

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

AboutFAQFeedbackTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

The projectAboutFAQFeedback
LegalTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

All bills
H.R. 4306·119th Congress·Introduced Jul 10, 2025

Food Chemical Reassessment Act of 2025

IntroducedHealthMajor
View bill text
Sponsor
Rep. Schakowsky, Janice D. [D-IL-9]
Committees
Energy and Commerce Committee (primary)
Last action
Jul 10, 2025

Bottom line

This bill aims to enhance food safety by requiring regular, systematic re-evaluation of various food chemicals and additives by the FDA, with specific substances prioritized for initial review.

What it actually does

This bill amends the Federal Food, Drug, and Cosmetic Act to mandate that the FDA's Office of Food Chemical Safety, Dietary Supplements, and Innovation systematically reassess the safety of at least 10 food-related substances or classes every three years, beginning in 2026. It also requires the re-establishment of the Food Advisory Committee to guide this process.

Proponents argue

Proponents argue that current food chemical safety regulations are outdated and do not adequately account for new scientific understanding or cumulative exposure risks. They assert that regular reassessments are crucial to protect public health, especially for vulnerable populations, and to ensure that substances deemed safe decades ago still meet modern safety standards.

Opponents contend

Opponents might argue that the existing FDA approval process is robust and that mandating frequent reassessments could create unnecessary regulatory burdens, stifle innovation in the food industry, and lead to arbitrary removal of substances without clear scientific justification, potentially increasing food costs or limiting consumer choices.

The bill is short and relatively straightforward, allowing for a quick and comprehensive understanding of its core provisions.

Section 2, amending Section 409(l)(1) of the Federal Food, Drug, and Cosmetic Act

Mandated Systematic Reassessment of Food Chemicals

prominently featuredmoderately complex

This provision requires the FDA's Office of Food Chemical Safety, Dietary Supplements, and Innovation to systematically and continuously reassess the safety of at least 10 substances or classes of substances every three years, starting in 2026. These substances include food additives, color additives, generally recognized as safe (GRAS) substances, prior-sanctioned substances, and food contact substances.

GroupImpactMechanismScale
GroupConsumersImpactIncreased safety assurance regarding food chemicals.MechanismRegular scientific review and potential removal of unsafe substances from the food supply.ScaleBroad, affecting all consumers of processed foods.
GroupFood Industry (manufacturers, ingredient suppliers)ImpactIncreased regulatory scrutiny and potential need to reformulate products.MechanismFDA's authority to amend or repeal regulations for substances found unsafe.ScaleSignificant, particularly for companies using substances under review.

Supporters argue

Supporters argue this ensures the food supply remains safe by updating assessments based on new science, protecting public health from potentially harmful chemicals that may have been approved under older standards.

Critics contend

Critics may contend this imposes an undue burden on the food industry, requiring costly reformulations and potentially removing substances without sufficient evidence of harm, leading to higher consumer prices.

Tradeoffs

Balances public health protection through updated safety reviews against potential regulatory burdens and costs for the food industry.

Section 2, amending Section 409(l)(2) and (3) of the Federal Food, Drug, and Cosmetic Act

Public Notice and Regulatory Action for Unsafe Substances

prominently featuredstraightforward

This provision mandates that the FDA provide public notice of all reassessment determinations. If a reassessment demonstrates a substance is not safe, the FDA must take appropriate regulatory action, such as amending or repealing regulations for food or color additives, publicly declaring GRAS substances unsafe, revoking prior-sanctioned uses, or deeming pre-market notifications for food contact substances ineffective.

Section 2, amending Section 409(l)(4) of the Federal Food, Drug, and Cosmetic Act

Prioritization of Substances for Reassessment

prominently featuredstraightforward

The bill directs the Secretary of Health and Human Services (via the FDA) to prioritize substances or classes of substances for reassessment based on public health need. It also provides an initial list of 10 specific substances or classes that 'may' be selected as the first group for reassessment, including Tert-butylhydroquinone, Titanium dioxide, various food dyes, Perchlorate, Butylated hydroxyanisole (BHA), Butylated hydroxytoluene (BHT), Trichloroethylene, Methylene chloride, Benzene, Ethylene chloride, Propyl gallate, Sodium benzoate, and Sodium nitrite.

Section 2, amending Section 409(l)(6) of the Federal Food, Drug, and Cosmetic Act

Re-establishment of Food Advisory Committee

prominently featuredstraightforward

This provision requires the Secretary to re-establish the Food Advisory Committee within 180 days of the bill's enactment. This committee will advise the Secretary with respect to the standards for reassessments conducted under this section and the process and methods necessary for the Office of Food Chemical Safety, Dietary Supplements, and Innovation to complete its work.

FOUND

This 'Rule of construction' clause clarifies that the new requirements for food safety reassessments do not alter the existing authority or duties of the Secretary (of HHS, via FDA) regarding the administration and enforcement of other provisions of Section 409 of the Federal Food, Drug, and Cosmetic Act.

Section 2, amending Section 409(l)(5) of the Federal Food, Drug, and Cosmetic Act

Why it matters:This is standard legislative practice to prevent unintended interpretations that might diminish existing regulatory powers. It is not evasive but ensures legal clarity and continuity of FDA's broader responsibilities.

Case for: Supporters would argue it's essential for legal clarity, ensuring that the new reassessment duties complement rather than supersede FDA's ongoing responsibilities and existing enforcement mechanisms under the Federal Food, Drug, and Cosmetic Act.

Case against: No specific case against this standard legal clarification, as it merely preserves existing authority and does not introduce new policy.

Estimated impact: Minimal direct impact on policy, but significant for maintaining the integrity and breadth of FDA's existing regulatory framework and preventing legal challenges based on conflicting authorities.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

On this page

  • Executive summary
  • Key provisions
  • Buried treasure
  • Follow the money
  • Critical analysis
  • Questions to ask
  • Implementation
  • Political analysis
Ask Ledger AI about this